Literature DB >> 6981704

Serum autoantibodies in systemic lupus erythematosus and correlation with cutaneous features.

D R Synkowski, M Reichlin, T T Provost.   

Abstract

Eighty-eight untreated systemic lupus erythematosus patients collected from rheumatology services were studied for the presence of discoid, molar and vasculitic lesions and photosensitivity. Their sera were examined for antibodies to native deoxyribonucleic acid (nDNA), nuclear ribonuclear protein (nRNP), the non-nucleic acid nuclear macromolecule Sm, the nuclear and cytoplasmic macromolecules La(SSB) and the predominantly cytoplasmic macromolecule Ro(SSA). These studies demonstrated that 42% of the lupus patients possessed nDNA; 36% nRNP; 24% Ro(SSA) and 9% anti La(SSB) antibodies. Six patients failed to demonstrate significant antinuclear antibody titers (mouse liver substrate), and 4 of these possessed anti Ro(SSA) antibodies. Correlation to the cutaneous lesions among this lupus population possessing various serum antibodies revealed a trend toward photosensitivity and molar dermatitis in the Ro(SSA), La(SSB), Ro/la and the ANA negative, ANA negative/Ro positive groups of lupus patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6981704

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Autoantibodies and disease activity in patients with discoid lupus erythematosus.

Authors:  Andrew Kim; Jack O'Brien; Lin-Chiang Tseng; Song Zhang; Benjamin F Chong
Journal:  JAMA Dermatol       Date:  2014-06       Impact factor: 10.282

2.  Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies.

Authors:  A Kenderov; V Minkova; D Mihailova; N Giltiay; S Kyurkchiev; I Kehayov; M Kazatchkine; S Kaveri; A Pashov
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

3.  Anti-Ro antibody and cutaneous vasculitis in systemic lupus erythematosus.

Authors:  Márcio Veronesi Fukuda; Simone Chinwa Lo; Cláudia Salvini de Almeida; Samuel Katsuyuki Shinjo
Journal:  Clin Rheumatol       Date:  2008-11-25       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.